| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 16VY3TM7ZO |
| InChI Key | OQGRFQCUGLKSAV-JTQLQIEISA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C13H14N2O3 |
| Molecular Weight | 246.27 |
| AlogP | 0.15 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 75.27 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 18.0 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Glioma | 2 | D005910 | ClinicalTrials |
| Colorectal Neoplasms | 2 | D015179 | ClinicalTrials |
| Mesothelioma | 2 | D008654 | ClinicalTrials |
| Prostatic Neoplasms | 2 | D011471 | ClinicalTrials |
| Lymphoma, Mantle-Cell | 2 | D020522 | ClinicalTrials |
| Stomach Neoplasms | 2 | D013274 | ClinicalTrials |
| Prostatic Neoplasms | 2 | D011471 | ClinicalTrials |
| Astrocytoma | 2 | D001254 | ClinicalTrials |
| Carcinoma | 2 | D002277 | ClinicalTrials |
| Glioblastoma | 2 | D005909 | ClinicalTrials |
| Lymphoma | 2 | D008223 | ClinicalTrials |
| Neoplasms | 2 | D009369 | ClinicalTrials |
| Neuroblastoma | 2 | D009447 | ClinicalTrials |
| Oligodendroglioma | 2 | D009837 | ClinicalTrials |
| Small Cell Lung Carcinoma | 2 | D055752 | ClinicalTrials |
| Melanoma | 2 | D008545 | ClinicalTrials |
| Multiple Myeloma | 2 | D009101 | ClinicalTrials |
| Astrocytoma | 2 | D001254 | ClinicalTrials |
| Pancreatic Neoplasms | 2 | D010190 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
| Brain Neoplasms | 2 | D001932 | ClinicalTrials |
| Neuroectodermal Tumors, Primitive | 2 | D018242 | ClinicalTrials |
| Rhabdoid Tumor | 2 | D018335 | ClinicalTrials |
| Lymphoma, Non-Hodgkin | 2 | D008228 | ClinicalTrials |
| Head and Neck Neoplasms | 2 | D006258 | ClinicalTrials |
| Waldenstrom Macroglobulinemia | 2 | D008258 | ClinicalTrials |
| Ependymoma | 2 | D004806 | ClinicalTrials |
| Adrenal Cortex Neoplasms | 2 | D000306 | ClinicalTrials |
| Sarcoma | 2 | D012509 | ClinicalTrials |
| Urinary Bladder Neoplasms | 2 | D001749 | ClinicalTrials |
| Brain Neoplasms | 2 | D001932 | ClinicalTrials |
| Kidney Neoplasms | 2 | D007680 | ClinicalTrials |
| Liver Neoplasms | 2 | D008113 | ClinicalTrials |
| Glioma | 2 | D005910 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Ovarian Neoplasms | 2 | D010051 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
| Lung Neoplasms | 2 | D008175 | ClinicalTrials |
| Colonic Neoplasms | 2 | D003110 | ClinicalTrials |
| Meningioma | 2 | D008579 | ClinicalTrials |
| Glioma | 2 | D005910 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL1980825 |
| DrugBank | DB11702 |
| FDA SRS | 16VY3TM7ZO |
| SureChEMBL | SCHEMBL20772654 |
| ZINC | ZINC000001590366 |